- Katherine A. High, M.D., is expert in pediatric hematology and gene
PHILADELPHIA, Oct. 10 /PRNewswire-USNewswire/ -- A leading physician- scientist at The Children's Hospital of Philadelphia, Katherine A. High, M.D., has been elected to the Institute of Medicine. Dr. High has long been a leading researcher in hematology and gene therapy.
The Institute of Medicine (IOM) today announced the election of 65 new members from throughout the United States, in recognition of their major contributions to the advancement of medical sciences, health care and public health. Established in 1970 by the National Academy of Sciences, the IOM honors professional achievement in the health sciences and serves as a national resource for independent analysis and recommendations on issues related to medicine, biomedical sciences and health.
Current members of the Institute elect new members from a slate of candidates nominated for their professional achievement and commitment to service.
An internationally prominent hematologist and researcher, Katherine A. High, M.D., is the director of the Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia. She is the William H. Bennett Professor of Pediatrics at the University of Pennsylvania School of Medicine, and a Howard Hughes Medical Institute investigator. She also is a past president of the American Society of Gene Therapy.
Dr. High's studies of the molecular biology of the bleeding disorder hemophilia led to clinical trials of gene therapy for hemophilia at The Children's Hospital of Philadelphia. She leads a National Institutes of Health-funded laboratory and has contributed scores of papers to the scientific literature.
After graduating from Harvard College and the Uni
|SOURCE Children's Hospital of Philadelphia|
Copyright©2007 PR Newswire.
All rights reserved